Long standing heart disease should be better screened
Timo Strandberg, Hannu Vanhanen
Abstract
Timo Strandberg, Hannu Vanhanen
Abstract
EDITOR—The audit by Irving et al in Scotland in 1997 showed that management of cholesterol concentration was performed less optimally than the treatment of other risk factors in secondary prevention of coronary heart disease.1 Those who had had coronary bypass operations before 1994—before the Scandinavian simvastatin survival study2—were much less likely to receive treatment. Our experience in the Helsinki area in 1998 was similar.3 Patients whose coronary heart disease had been diagnosed …
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
EDITOR—The audit by Irving et al in Scotland in 1997 showed that management of cholesterol concentration was performed less optimally than the treatment of other risk factors in secondary prevention of coronary heart disease.1 Those who had had coronary bypass operations before 1994—before the Scandinavian simvastatin survival study2—were much less likely to receive treatment. Our experience in the Helsinki area in 1998 was similar.3 Patients whose coronary heart disease had been diagnosed …
Key concepts: Simvastatin, Coronary heart disease, Medicine, Internal medicine, Secondary prevention, Cardiology, Audit, Coronary disease